Ewing Sarcoma: Trabectedin & Irinotecan Target EWS::FLI1

New Drug Combination Marks Ewing Sarcoma Treatment Breakthrough in Phase 1/2 Trial In a pivotal shift for pediatric and adolescent oncology, a new therapeutic strategy is showing remarkable promise in treating one of the most challenging bone cancers. Researchers have unveiled a potent combination therapy targeting the genetic engine of Ewing sarcoma, yielding what experts … Read more

Bacteria Fight Colorectal Cancer: Novel Drug Delivery

The fight against colorectal cancer, a disease projected to cause the second-most cancer deaths in 2025, is entering a new era. Researchers at Baylor University have demonstrated a promising new strategy: weaponizing a common food-borne bacterium, Listeria monocytogenes, to deliver potent cancer-killing proteins directly into tumor cells. This isn’t simply a novel approach; it represents … Read more